InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

- Current share price for NSB : $0.064

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Notice of Annual General Meeting/Proxy Form 29 Oct 2019 5:57PM $0.240 $0.064 fallen by 73.33%
$25 Appendix 4C - quarterly 28 Oct 2019 3:21PM $0.230 $0.064 fallen by 72.17%
$25 NSB Correction to Presentation 24 Oct 2019 8:31AM $0.230 $0.064 fallen by 72.17%
$25 NSB - Techknow Conference Presentation Oct 19 22 Oct 2019 3:11PM $0.225 $0.064 fallen by 71.56%
$25 Appendix 3B - Options Exercised 3 Oct 2019 6:09PM $0.225 $0.064 fallen by 71.56%
$25 EmtinB Can Become a Revolutionary Treatment for Glaucoma 1 Oct 2019 9:31AM $0.245 $0.064 fallen by 73.88%
$25 Trading Halt 27 Sep 2019 9:20AM $0.245 $0.064 fallen by 73.88%
$25 NSB Receives R&D Advanced Overseas Finding 2 Sep 2019 8:28AM $0.245 $0.064 fallen by 73.88%
$25 Appendix 4E and Annual Report 30 Aug 2019 1:35PM $0.220 $0.064 fallen by 70.91%
$25 NSB Invited to Present at Bio Investor Forum - San Francisco 14 Aug 2019 8:19AM $0.265 $0.064 fallen by 75.85%
$25 Appendix 3B - Options Exercised 9 Aug 2019 7:20PM $0.250 $0.064 fallen by 74.40%
$25 NSB - FInal Data Received from Spinal Cord Injury Model 31 Jul 2019 9:51AM $0.300 $0.064 fallen by 78.67%
$25 Appendix 4C - quarterly 30 Jul 2019 7:00PM $0.300 $0.064 fallen by 78.67%
$25 Trading Halt 30 Jul 2019 9:18AM $0.300 $0.064 fallen by 78.67%
$25 Appendix 3B - Escrow Release 25 Jul 2019 5:36PM $0.300 $0.064 fallen by 78.67%
$25 Appendix 3B - Options Exercised 19 Jul 2019 4:52PM $0.280 $0.064 fallen by 77.14%
$25 Notice under ASX Listing rule 3.10A 9 Jul 2019 7:05PM $0.320 $0.064 fallen by 80%
$25 Appendix 3B - Options Exercised 8 Jul 2019 8:18AM $0.335 $0.064 fallen by 80.90%
$25 NSB - Breakthrough results from Spinal Cord Injury Model 2 Jul 2019 9:56AM $0.145 $0.064 fallen by 55.86%
$25 Trading Halt 1 Jul 2019 9:43AM $0.145 $0.064 fallen by 55.86%
$25 Investor Presentation 12 Jun 2019 8:22AM $0.140 $0.064 fallen by 54.29%
$25 R&D Update 16 May 2019 8:25AM $0.160 $0.064 fallen by 60%
$25 Appendix 4C - quarterly 29 Apr 2019 11:56AM $0.160 $0.064 fallen by 60%
$25 Investor Presentation 19 Mar 2019 8:21AM $0.175 $0.064 fallen by 63.43%
$25 Shareholder update 5 Mar 2019 10:57AM $0.200 $0.064 fallen by 68%

326 - 350 of 406 results

Page 14 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.